Stay updated on COMBI-AD Trial: Dabrafenib + Trametinib in Melanoma

Sign up to get notified when there's something new on the COMBI-AD Trial: Dabrafenib + Trametinib in Melanoma page.
Latest website image capture
Clouds background image

Latest updates to the COMBI-AD Trial: Dabrafenib + Trametinib in Melanoma page

  1. Check
    7 days ago
    No Change Detected
  2. Check
    14 days ago
    Change Detected
    Summary
    Revision: v3.4.2 was added as the latest version in the study's history, replacing the earlier v3.4.1. The notice about government funding and operating status was removed from the page.
    Difference
    0.3%
    Check dated 2026-02-11T09:27:53.000Z thumbnail image
  3. Check
    21 days ago
    Change Detected
    Summary
    The page shows two minor administrative updates: a site-wide notice regarding government funding and a new revision tag (v3.4.1) that supersedes v3.4.0. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.3%
    Check dated 2026-02-04T05:56:02.000Z thumbnail image
  4. Check
    28 days ago
    Change Detected
    Summary
    The history page adds a glossary display option and color-coded highlights for additions and deletions, and updates the revision label from v3.3.4 to v3.4.0.
    Difference
    0.3%
    Check dated 2026-01-28T04:28:33.000Z thumbnail image
  5. Check
    42 days ago
    Change Detected
    Summary
    Revision history updated: added Revision v3.3.4 and removed Revision v3.3.3.
    Difference
    0.0%
    Check dated 2026-01-14T01:16:51.000Z thumbnail image
  6. Check
    64 days ago
    Change Detected
    Summary
    A new Revision: v3.3.3 was added, and the HHS Vulnerability Disclosure link as well as the previous Revision: v3.3.2 entry were removed.
    Difference
    0.1%
    Check dated 2025-12-23T08:13:38.000Z thumbnail image
  7. Check
    85 days ago
    Change Detected
    Summary
    The page history shows a minor revision update (v3.3.2) replacing v3.3.1, a footer-level change with no impact on core content. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2025-12-01T17:24:18.000Z thumbnail image

Stay in the know with updates to COMBI-AD Trial: Dabrafenib + Trametinib in Melanoma

Enter your email address, and we'll notify you when there's something new on the COMBI-AD Trial: Dabrafenib + Trametinib in Melanoma page.